AptaMatrix, Inc. news

AptaMatrix, Inc., a Syracuse-based biotech company focused on developing aptamer-based technologies for diagnostic applications, announces that it has been awarded a $2M Phase II Small Business Innovation Research (SBIR) grant by the National Institute of General Medical Sciences (NIGMS) institute of the National Institutes of Health (NIH).

The Phase II award will allow AptaMatrix to develop and optimize their novel, aptamer-based, plasma proteome assay designed to operate on existing